ASAH2
Basic information
Region (hg38): 10:50182778-50279720
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (35 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASAH2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000019893.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 34 | 35 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 34 | 1 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ASAH2 | protein_coding | protein_coding | ENST00000395526 | 20 | 65833 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00427 | 0.877 | 124583 | 9 | 1156 | 125748 | 0.00464 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.346 | 123 | 134 | 0.916 | 0.00000686 | 5076 |
| Missense in Polyphen | 38 | 39.644 | 0.95852 | 1949 | ||
| Synonymous | -1.46 | 62 | 49.0 | 1.27 | 0.00000246 | 1516 |
| Loss of Function | 1.32 | 5 | 9.36 | 0.534 | 5.62e-7 | 480 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0131 | 0.0130 |
| Ashkenazi Jewish | 0.00397 | 0.00398 |
| East Asian | 0.000218 | 0.000217 |
| Finnish | 0.00864 | 0.00863 |
| European (Non-Finnish) | 0.00581 | 0.00578 |
| Middle Eastern | 0.000218 | 0.000217 |
| South Asian | 0.000849 | 0.000850 |
| Other | 0.00391 | 0.00375 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid at an optimal pH of 6.5-8.5 (PubMed:10781606, PubMed:26190575). Acts as a key regulator of sphingolipid signaling metabolites by generating sphingosine at the cell surface. Acts as a repressor of apoptosis both by reducing C16- ceramide, thereby preventing ceramide-induced apoptosis, and generating sphingosine, a precursor of the antiapoptotic factor sphingosine 1-phosphate. Probably involved in the digestion of dietary sphingolipids in intestine by acting as a key enzyme for the catabolism of dietary sphingolipids and regulating the levels of bioactive sphingolipid metabolites in the intestinal tract. {ECO:0000269|PubMed:10781606, ECO:0000269|PubMed:15946935, ECO:0000269|PubMed:16061940, ECO:0000269|PubMed:26190575}.;
- Pathway
- Sphingolipid signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Metabolism of lipids;Metabolism;Glycosphingolipid metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;sphingosine and sphingosine-1-phosphate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.129
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.168
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asah2
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- sphingosine metabolic process;ceramide metabolic process;apoptotic process;response to organic substance;long-chain fatty acid biosynthetic process;sphingosine biosynthetic process;ceramide catabolic process
- Cellular component
- extracellular region;mitochondrion;plasma membrane;integral component of membrane
- Molecular function
- calcium ion binding;zinc ion binding;N-acylsphingosine amidohydrolase activity;ceramidase activity